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Road, Sandwich, Kent CT13 9NJ, UK.The sensitization of spinal dorsal horn neurones leads to prolonged enhancement of pain behaviour and
can be evoked by intense C-ﬁbre stimulation, tissue inﬂammation and peripheral nerve injury. Activation
of central immune cells plays a key role in establishing pain hypersensitivity but the exact nature of the
afferent input that triggers the activation of microglia and other glial cells within the CNS, remains
unclear. Here intense but non-damaging, electrical stimulation of intact adult rat C-ﬁbres for 5 min at
10 Hz induced central sensitization characterized by signiﬁcant decreases in mechanical withdrawal
thresholds 3, 24 and 48 h later. This maintained (>3 h) hypersensitivity was not observed following top-
ical skin application of capsaicin. C-ﬁbre evoked sensitization was accompanied by signiﬁcant microglial
activation, shown by increased Iba-1 immunoreactivity throughout the dorsal horn at 24 and 48 h and
signiﬁcant upregulation of markers of microglial activation: IL-6 and Mcp-1 at 3 h and Mmp3, CSF-1
and CD163 at 24 and 48 h. C-ﬁbre stimulation caused no nerve damage at ultrastructural and molecular
levels. Lower intensity stimulation that did not activate C-ﬁbres or sham stimulation did not increase Iba-
1 immunoreactivity or induce behavioural sensitivity. Pre-treatment with minocycline (40 mg/kg, i.p.)
prevented the C-ﬁbre evoked sensitization and microglial activation. Identical C-ﬁbre stimulation in
10-day old rat pups failed to activate microglia or change behaviour. These results demonstrate that a
brief period of low frequency C-ﬁbre stimulation, in the absence of nerve damage, is sufﬁcient to activate
microglia resulting in behavioural hyperalgesia.
 2009 International Association for the Study of Pain. Published by Elsevier B.V.
Open access under CC BY license.1. Introduction
Prolonged alterations in sensory processing occur following
peripheral inﬂammatory or neuropathic injury. These changes are
not exclusively determined by peripheral sensory afferent activity,
but also reﬂect modiﬁcations of the central processing of sensory
information [61,62]. Nociresponsive networks in the dorsal horn
are dynamic and can be profoundly altered by intense peripheral
sensory stimulation leading to the induction of the phenomenon
of central sensitization, a state where the response to noxious
and innocuous stimuli is greatly enhanced [35,61]. Injury-induced
central sensitization in the spinal dorsal horn is thought to under-
pin much of the allodynia and hyperalgesia that characterize acute
and chronic pain.
The decrease in pain thresholds that characterize central sensi-
tization is associated with an increase in the responsiveness of dor-
sal horn neurons and alterations in gene expression [64]. Stimulitudy of Pain. Published by Elsevie
.
y).
ch & Development, Ramsgatethat can produce central sensitization include tissue inﬂammation
and nerve injury [12,21,26] but the key to central sensitization is
that it requires intense or repetitive C-ﬁbre nociceptor stimulation
[20,54,65]. The prolonged LTP evoked in lamina I cells by both low
and high frequency C-ﬁbre stimulation is likely to be an important
mechanism underlying the synaptic potentiation of stimulated
afferents [48,51,54] along with a wider heterosynaptic facilitation
of the NMDA receptor by convergent intracellular biochemical cas-
cades in dorsal horn neurons [5,24,49].
It is becoming increasingly evident that the cellular changes
associated with central sensitization are not restricted to neurons,
and that non-neuronal cell types, particularly immune cells play a
key role in the induction and maintenance of prolonged states of
pain hypersensitivity [10,52,58]. Of particular interest are microg-
lia. These are the primary immunocompetent cell type within the
CNS serving a major role in the immune response to tissue injury
or infection [28,60]. Exogenous application of activated microglia
into the dorsal horn results in reduced sensory thresholds similar
to those associated with central sensitization [39,58]. In patholog-
ical pain states, such as following peripheral nerve injury, the
involvement of microglia has been clearly demonstrated [7,16]
and proinﬂammatory cytokines released by microglia have re-
cently been shown to cause central sensitization and hyperalgesiar B.V.Open access under CC BY license.
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[25].
While the link between tissue injury, microglial activation and
hyperalgesia is strong, the nature of the afferent signals that trig-
ger microglial activation is still not clear [36]. Identifying such
factors might provide important targets for the treatment of
chronic pain. We have tested whether direct stimulation of C-ﬁ-
bres in uninjured animals, at intensities known to cause central
sensitization, is sufﬁcient to cause microglial activation in the
dorsal horn.
2. Methods
All animal procedures were licensed by the UK Home Ofﬁce and
performed in accordance with the Animals (Scientiﬁc Procedures)
Act 1986. Animals (Sprague–Dawley rats) were housed in cages
of six age-matched animals (adult males) or alongside their moth-
ers and littermates (neonates) with free access to food and water.
The room in which animals were housed had a 12-h light/dark
cycle.
2.1. Adult and P10 (postnatal day 10) electrical stimulation protocol
Rats were anaesthetized with isoﬂurane (Abbott Animal
Health, Queensborough, UK (1.5%)) and oxygen and body temper-
ature maintained using a homeothermic-heated blanket (Harvard
Apparatus, Kent, UK). Surgery was performed in sterile conditions,
in a Bassaire P4VF (Southampton, UK) positive pressure hood
using aseptic techniques. The left sciatic nerve was exposed via
an incision through the thigh, the overlying muscle was moved
aside using blunt dissection and the nerve dissected free of peri-
neural membranes. The exposed nerve was electrically isolated
from the surrounding muscle and other tissues by placing a small
piece of plastic sheet under the nerve. Two silver wire electrodes
were placed under the exposed sciatic nerve. Care was taken to
ensure that the electrodes were only in contact with the nerve
and that the sciatic nerve was never stretched. Trains of electrical
stimuli were applied for 5 min at 10 Hz at different pulse widths
and intensities, to recruit the following afferent ﬁbre groups:- Ab
and Ad ﬁbres (150 ls, 5 mA,) or Ab, Ad and C-ﬁbres (500 ls,
10 mA) as described elsewhere [32,63]. These two experimental
groups of rats were labeled the ‘‘Ab/Ad” and ‘‘C” groups. A
sham-operated group that underwent surgery and electrode
placement but did not receive electrical stimulation was also in-
cluded. Stimuli were generated using a Neurolog (Digitimer,
Welwyn Garden City, UK) NL300 pulse generator, an NL510 pulse
buffer and an NL800 stimulus isolator. Following stimulation,
electrodes were carefully removed, the muscle and skin sutured
using 5/0 Mersilk (Ethicon, Edinburgh, UK) and the animals re-
turned to their home cage to recover with free access to food
and water. Identical procedures were followed in both adults
and the P10 group.
2.2. Capsaicin stimulation protocol
Adult rats were anaesthetized as above and 20 lg of capsaicin
(8-methyl-N-vanillyl-6-nonamide) or 0.9% saline was injected into
the plantar foot pad of one hindpaw in a volume of 10 lL. Capsaicin
was prepared in polyxyethylene (20) sorbitan (Tween 80) saline
vehicle as described previously [14] and injected using a 28G nee-
dle. Mechanical thresholds were established before capsaicin
application and again 3, 24 and 48 h post capsaicin, using methods
described below. Following the 48-h time point animals were
killed and tissue processed for immunohistochemical evaluation
of Iba-1 immunoreactivity (see below).2.3. Minocycline inhibition of microglia activation
Adult rats were pre-emptively treated with minocycline
(40 mg/kg; Sigma UK) i.p. 1 h prior to sciatic nerve stimulation
(C-ﬁbre strength or sham) and then every 24 h until the animals
were killed and the spinal cord collected for Iba-1 immunohisto-
chemical analysis (see below). Mechanical withdrawal thresholds
were measured before stimulation and then 3, 24, and 48 h post
stimulation as described below.
2.4. Immunohistochemistry
Adult and P10 rats were given an overdose of pentobarbitone
[100 mg/mL] and transcardially perfused with cool heparinised
saline followed by cool 4% paraformaldehyde. The lumbar spinal
cord was removed, post-ﬁxed (4% paraformaldehyde solution)
and stored in 30% sucrose in 0.1 M phosphate buffer/0.02% sodium
azide solution at 4 C. Immunohistochemical staining was per-
formed on 40 lm free-ﬂoating cryosections of L3/L4/L5 spinal cord.
For Iba-1, the sections were blocked for 1hr in TTBS (0.05 M Tris
saline, pH7.4/0.3% Triton-X100) containing 1% normal goat serum
(NGS) at room temperature (RT). Sections were then incubated at
4 C for 72 h with rabbit a-Iba-1 (Wako, Japan) diluted 1:2000 in
TTBS. Three 10 min washes in 0.1 M phosphate buffer (PB) were
carried out between all subsequent steps. Sections were incubated
for 2 h at room temperature with Alexa 488 conjugated goat a-rab-
bit secondary antibody (Molecular probes, Oregon) diluted 1:200
in TTBS. Iba-1 immunostaining was analysed by measuring the
intensity of ﬂuorescence within a deﬁned region of the dorsal horn
using MCID-1 software (London UK). The L3-5 dorsal horn was di-
vided into a medial, middle and lateral third in the dorsoventral
plane and ﬂuorescence intensity measured medially and laterally
both ipsi and contralateral to sciatic nerve stimulation. Contralat-
eral intensity was treated as basal and intensity changes in the
ipsilateral side calculated as a percentage of contralateral values.
Statistical analyses were performed using one-way ANOVA with
the Bonferroni post-test.
2.5. Sciatic nerve ultra-thin section microscopy
Three days following sciatic stimulation adult rats were per-
fused transcardially with 4% paraformaldehyde 2% gluteraldehyde
in 0.1 M PB. Tissue was post ﬁxed for a minimum of 72 h in ﬁxative
and embedded in Epon. Sections were cut through the stimulation
site at 0.5 lm and stained with toluidine blue. Sections were
extensively examined under the light microscope for signs of axo-
nal degeneration, leukocyte inﬁltration and shrunken or swollen
axons.
2.6. Behavioural testing
Behavioural testing was performed in control rats (sham-oper-
ated or control saline intra-plantar injection), and experimental rats
(sciatic nerve C-ﬁbre stimulation groups and intra-plantar capsai-
cin group) in both adult and P10 rat pups. Basal mechanical with-
drawal thresholds were determined in rats at least one day prior
to the test procedure to habituate them to the room, the investiga-
tor and the procedure. Thresholds were tested again immediately
before anaesthetizing and then at 3, 24 and 48 h post-stimulation.
Flexion withdrawal reﬂex thresholds were established in both the
groups to punctate mechanical stimulation of the plantar surface
of the hindpaw using calibrated von Frey ﬁlaments (VF) that exert
a reproducible stimulus strength in grams. (Stoelting, Woodvale,
IL). Filaments were applied sequentially to the plantar surface of
the hind paw 10 times at intervals of 1 s. Response threshold was
Fig. 1. C-ﬁbre strength electrical stimulation of the sciatic nerve induces a
prolonged sensitization of mechanical withdrawal thresholds. (A) Thresholds were
signiﬁcantly decreased in the ipsilateral paw of stimulated rats when compared to
sham animals and contralateral thresholds. (B) Activation of TRPV1 positive C-ﬁbres
with capsaicin also signiﬁcantly reduced thresholds, however this was not as
prolonged as that seen with electrical stimulation. Bars indicate mean ± SEM.
Values are the means of 6–8 animals in each group. Asterisks indicate statistically
signiﬁcant differences between groups (two-way ANOVA with Bonferroni post-test)
*P < 0.05, **P < 0.01 (electrical stimulation) #P < 0.05 (capsaicin stimulation).
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in 5 of 10 applications.
To assess the ability of C-ﬁbre strength electrical stimulation to
induce central sensitization over the 48 h duration of the study, re-
peated measures two-way ANOVA’s were performed between
sham, C-ﬁbre (ipsilateral and contralateral mechanical withdrawal
thresholds as separate groups) and capsaicin-stimulated groups.
Where ANOVA’s were signiﬁcantly different (P < 0.05) the Bonfer-
roni post-tests were performed to determine the degree of signiﬁ-
cance. The effect of minocycline upon behavioural responses 24 h
after sciatic nerve C-ﬁbre stimulation was tested using a Student’s
t-Test.
2.7. RNA extraction
Fresh tissue was collected 3, 24 and 48 h after C-ﬁbre stimula-
tion or sham surgery (n = 4 animals per experimental group). Rats
were sacriﬁced with 0.1 mL of Euthanal, the ipsilateral side of the
dorsal horn was snap frozen on liquid nitrogen and stored at
80 C until RNA extraction. RNA was extracted using Trizol re-
agent (Invitrogen) and QIAshredder column (Qiagen) for homog-
enisation according to manufacturer’s protocols. Additionally, the
RNA was cleaned by an RNA puriﬁcation column (Qiagen) and a
ﬁnal volume of 20 lL was obtained according to manufacturer pro-
tocol. The amount of RNA was measured with a NanoDrop ND-
1000 Spectrophotometer (NanoDrop Technologies, Inc.). Then,
the RNA was stored at 80 C until cDNA synthesis. For cDNA
synthesis, 2 lg of RNA and 100 pmol/lL of the T7(dT)24 primer
(50-GGCCAGTGAATTGTAATACGACTCACTATAGGGAGGCGGTTTTTTT
TTTTTTTTTTTTTTTTT-30) were combined for annealing at 55 C for
5 min and chilled on ice for 2 min. Then, the SuperScript III kit
(Invitrogen) was added according to manufacturer indications
to synthesize the cDNA.
2.8. Quantitative real-time PCR
Speciﬁc primers for microglial markers were designed and syn-
thesized by Sigma-Genosys (Supplementary Table I). An SYBR
green-based system (SIGMA) was used for ampliﬁcation and
detection. 1 lL of cDNA product per sample, 12.5 lL of SYBR
Green JumpStartTM Taq ReadyMixTM for quantitative PCR and
200 nM/primer was used for cocktail reaction. The ampliﬁcation
protocol was: step 1 at 95 C for 5 min, step 2 at 95 C for
30 min, step 3 at 60 C for 30 min, step 4 at 70 C for 30 min, step
5 plate reading, 39 cycles from step 2 to 4 and a ﬁnal melting curve
from 60 to 90 C with reading every 0.5 C and 1 min hold. The
reaction plate was then placed in a DNA Engine Pelter thermal cy-
cler with a Chromo 4 real-time PCR detector (Bio-Rad). The ampli-
ﬁcation process was monitored with Opticon Monitor v3.1.32
software (MJ Genework Inc.).
The reported ﬂuorescence was obtained with a standard curve
of serial dilutions of a cDNA calibrant. We performed a standard
curve per gene using the corresponding speciﬁc primers. We set
up a ‘threshold’ in the lineal range right above the baseline noise
in order to obtain an r2 < 0.999 in the regression curve to accu-
rately determine the ﬂuorescence.
The DNA products from the qPCRs were sequenced on an AB
PRISM 3100-Avant automated DNA capillary sequencer (AB Ap-
plied Biosystems, Lingley House, 120, Birchwood Boulevaid, War-
rington) using BigDye Terminator v1.1 Cycle Sequencing
chemistry (AB Applied Biosystems). Sequencing reactions were
performed and precipitated in accordance with the manufacturers
instructions using the same sense or forward primer that was used
for the qPCR ampliﬁcation (Supplementary Table I). The reactions
were resolved on a 50 cm standard sequencing capillary, running
optimal 3100 POP-6TM polymer (AB Applied Biosystems). Se-quence data were extracted and analysed using AB PRISM 3100-
Avant Data Collection Software v2.0 and DNA Sequencing Analysis
Software v5.1.1, respectively (AB Applied Biosystems).
Pooled qPCR data from each experimental group (four animals
per group and two technical replicates for each sample to make
n = 8) were plotted as ‘‘mean intensity normalized” (MIN) ±stan-
dard deviation. The normalization was calculated as the percent-
age ratio with the housekeeping gene GAPDH. All data were
exported to SigmaStat, 2.03 (SPSS Inc) for statistical analysis.
3. Results
3.1. Low frequency electrical stimulation of the sciatic nerve at C-ﬁbre
strength causes behavioural sensitization
Electrical stimulation of the sciatic nerve at 10 Hz for 5 min at
intensities sufﬁcient to activate C-ﬁbres (10 mA, 500 ls) resulted
in a signiﬁcant reduction in ipsilateral paw withdrawal thresholds
to mechanical stimulation that lasted for over 48 h (Fig. 1A, ipsilat-
eral C-ﬁbre group vs sham; P < 0.05 (3 h) P < 0.01 (24 h), P < 0.05
(48 h) n = 8 per group). No signiﬁcant changes in paw withdrawal
thresholds were observed in sham-operated animals (Fig. 1A).
Unilateral subcutaneous injection of capsaicin into the plantar
surface of the hindpaw also signiﬁcantly decreased mechanical
thresholds although this reduction was short-lived compared to
that observed with C-ﬁbre strength electrical stimulation of the
G.J. Hathway et al. / PAIN 144 (2009) 110–118 113sciatic nerve. The reduction in the capsaicin treated rats was only
signiﬁcant at the 3-h time point (Fig. 1B; P < 0.05, n = 6). By 24 h,
mechanical thresholds had returned to baseline values. Mechanical
withdrawal thresholds in the C-ﬁbre stimulation group were sig-
niﬁcantly lower at this time point (24 h; P < 0.01, n = 6 and 8 cap-
saicin and C-ﬁbre groups, two-way ANOVA).
3.2. Sciatic nerve stimulation at C-ﬁbre, but not Ab/Ad, strength
activates microglia in the dorsal horn
In separate groups of animals, lumbar spinal cord tissue was ta-
ken at 3, 24 and 48 h time points post-stimulation and was immu-
nostained for Iba-1. The expression pattern of activated microglia
in the dorsal horn was compared in sham, Ab/Ad, and C-ﬁbre stim-
ulated rats (Fig. 2). The pattern of Iba-1 expression in sham-oper-Fig. 2. Electrical stimulation of the adult rat sciatic nerve is associated with changes in
immunoreactive microglia in the dorsal horn of rats that had undergone sham surger
previously. The greatest expression was in the lateral aspect of the dorsal horn for sham
Comparisons of the Iba-1 expression in this area are shown in the high power (X40) imated and Ab/Ad group dorsal horn was indistinguishable. In both
the groups, levels of Iba-1 expression were low except for a local-
ized increase in Iba-1 immunoreactivity in the dorsal laminae of
the ipsilateral side in the lateral L3/4 segments corresponding to
the termination site of afferents damaged by the surgical incision
to expose the sciatic nerve in the upper leg (Fig. 2). Examination
of microglia within this region showed characteristic morphologi-
cal changes and amoeboid cell bodies associated with microglial
activation.
The pattern of Iba-1 expression and the morphology of the
microglia within the dorsal horn of the C-ﬁbre group were quite
different (Fig. 2). In this group the level of Iba-1 immunoreactivity
in the ipsilateral dorsal horn was substantially increased particu-
larly in the medial portion within the somatotopic area associated
with sciatic nerve termination at the 24 h (data not shown) andIba-1 immunoreactivity in the L4 spinal dorsal horn. Expression patterns of Iba-1
y or where the sciatic nerve was stimulated at Ab/Ad or C-ﬁbre intensities 48 h
, and Ab/Ad groups however in the C-ﬁbre group this area was in the medial aspect.
ages that are displayed in the right hand column. Scale bars are 50 lm.
Table 1
Summary of qPCR. The table shows mean fold change in the gene expression ± SD.
performed by comparison of the stimulated dorsal horn versus its counterpart sham
at 3, 24 or 48 h post C-ﬁbre stimulation. Mean fold changes are indicated (*P < 0.05,
power>80%).
Gene name Time post stimulation
3 h 24 h 48 h
IL-6 1.3 ± 0.3* 1.5 ± 0.8 1.0 ± 0.6
Mmp3 1.5 ± 0.7 1.8 ± 0.8* 0.9 ± 0.4
Mcp-1 1.4 ± 0.2* 1.3 ± 0.6* 1.6 ± 0.4*
CSF1 1.2 ± 0.6 1.3 ± 0.2* 1.8 ± 0.5*
CSFR1 1.0 ± 0.1 1 ± 0.4 1 ± 0.3
CD163 1.0 ± 0.1 1.7 ± 0 4* 0.9 ± 0.1
CD68 0.9 ± 0.5 1.3 ± 0.3 0.9 ± 0.5
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tween the groups at the 3 h time point. This change was accompa-
nied by altered microglial cell morphology to an amoeboid,
swollen shape. Quantiﬁcation of the Iba-1 immunoreactivity in
the different stimulus groups at 48 h post-stimulation is shown
in Fig. 3 which shows a signiﬁcant difference in Iba-1 intensity be-
tween sham and C-ﬁbre groups in the medial aspect of the dorsal
horn (P < 0.05, one-way ANOVA). To allow for inter-animal vari-
ability the ipsilateral dorsal horn ﬂuorescence intensity was calcu-
lated as a percentage of the contralateral value, although in the
C-ﬁbre group variable changes were observed in contralateral
microglial morphology.
3.3. Sciatic nerve stimulation at C-ﬁbre strength upregulates
microglial markers in the dorsal horn
In order to quantify dorsal horn microglial activation following
sciatic C-ﬁbre stimulation, mRNA levels of markers of microglia
activation were analysed using qPCR at 3, 24 and 48 h. Interleu-
kin-6 (IL-6), monocyte chemo attractant protein 1 (MCP-1),
metalloproteinase 3 (Mnp3) and the macrophage-speciﬁc colony-
stimulator factor-1 (CSF-1) were used as markers of the initiation
of microglial activation. Sustained microglial activation and migra-
tion were assessed by colony-stimulator factor-1 receptor (CSFR1),
the macrophage scavenger receptor CD163 (which tags resident
macrophages) and the macrophage marker of phagocytosis CD68
(which indicates the presence of inﬁltrating or activated
macrophages).
The ﬁndings are summarised in Table 1 and show two phases of
microglia activation. Firstly, there is a moderate but signiﬁcant in-
crease in the levels of compounds associated with the activation of
microglia, IL-6 at 3 h post-stimulation, Mmp3 at 24 h and CSF-1 at
both 24 and 48 h post C-ﬁbre stimulation. In addition, the chemo-
kine MCP-1 is increased at all three time points. The second phase
is consistent with the maintenance of microglial activation and
their migration to the affected tissue with upregulation of the
markers CD163 and CSFR1 24 h post C-ﬁbre stimulation. Interest-
ingly, there were no differences in the mRNA levels of the macro-
phage inﬁltration CD68 over the 48 h when compared to the shamFig. 3. Quantiﬁcation of the intensity of Iba-1 immunoreactivity in the medial
aspect of the L4 dorsal horn of rats stimulated 48 h previously at increasing
intensity shows clearly that increasing stimulus intensity leads to increased Iba-1
immunoreactivity. C-ﬁbre strength stimulation leads to signiﬁcantly greater Iba-1
immunoreactivity than in sham-operated spinal cord. Minocycline was able to
prevent the increase in intensity seen with untreated c-ﬁbre stimulated rats. Bars
indicate mean ± SEM. Values are the means of 6–8 animals in each group. **P < 0.01,
***P < 0.001.rats, suggesting that the activation following our stimulation pro-
tocol was restricted to resident microglia.
3.4. C-ﬁbre stimulation-evoked mechanical hypersensitivity and
microglial activation is prevented by minocycline treatment
Pre-treatment of rats with minocycline (40 mg/kg), a known
inhibitor of microglial activation, prior to C-ﬁbre strength electrical
stimulation of the sciatic nerve and then every 24 h thereafter, sig-
niﬁcantly reduced the stimulation evoked behavioural sensitiza-
tion at 3, 24 and 48 h. Fig. 4A shows that the mean fall in
mechanical threshold, 24 h after sciatic C-ﬁbre stimulation isFig. 4. (A) Pre-treating rats prior to surgery with the microglial inhibitor minocy-
cline (40 mg/kg, i.p.) and then every 24 h after surgery prevents the development of
central sensitization associated with sciatic nerve stimulation at intensities that
activate C-ﬁbres. The reduction in mechanical withdrawal threshold in freely
behaving rats at 24 h is prevented by pre-treating rats with minocycline (squares).
(B) Minocycline also prevents the high intensity expression of Iba-1 in the medial
portion of the dorsal horn of C-ﬁbre stimulated rats. Bars indicate mean ± SEM.
Values are the means of 6–8 animals in each group.*P < 0.05, **p < 0.01, #p < 0.05
minocycline group (Student t-Test).
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t-Test).
Analysis of the spinal cord with Iba-1 immunoreactivity showed
that minocycline treatment also prevented the increase in microg-
lial activation normally caused by sciatic nerve C-ﬁbre stimulation
(Fig. 4B). Quantitative analysis of Iba-1 immunoreactivity in the
L4-5 dorsal horn 48 h after C-ﬁbre stimulation shows that is signif-
icantly reduced by minocycline treatment (Fig. 3 P < 0.001, one-
way ANOVA).
These results demonstrate that brief low frequency C-ﬁbre
stimulation of the sciatic nerve leads to signiﬁcant behavioural
sensitization that persists beyond the stimulation period. Further-
more this sensitization is the result of microglial activation and can
be prevented by pre-treating the rats with minocycline.
3.5. C-ﬁbre electrical stimulation activates microglia and mechanical
hypersensitivity in the absence of nerve pathology
A number of investigations were performed to assess any path-
ological changes to the sciatic nerve associated with electrical
stimulation at C-ﬁbre strength. Previous studies have determined
that levels of Activating Transcription Factor 3 (ATF-3) signiﬁcantly
increase in the cell bodies of damaged primary afferent neurones
[4,59]. However, qPCR quantiﬁcation of ATF-3 mRNA in naive
and C-ﬁbre stimulated L4 and L5 dorsal root ganglia using poly-
merase chain reaction showed no signiﬁcant differences in ATF-3
mRNA levels clearly indicating a lack of axonal damage in these
two groups. This was in marked contrast to a sciatic axotomy
group (positive control), where levels of ATF-3 mRNA were signif-
icantly increased (5- to 6-fold) in the ipsilateral affected L4/5 dor-
sal root ganglia relative to the contralateral side (Fig. 5A) reﬂecting
the retrograde changes triggered in the cell bodies after axotomy.
Consistent with the lack of ATF3 expression, no differences were
observed in the density or pattern of peptidergic (CGRP) and non-
peptidergic C-ﬁbre (IB4) primary afferent terminal staining in theFig. 5. qPCR for ATF-3 a marker of neuronal damage shows no difference between
sham and c-ﬁbre stimulated rats, however in the positive control group (axotomy)
levels of ATF-3 were signiﬁcantly higher than those in either of the other two
groups (B) Toluidine blue staining of the sciatic nerve shows no gross pathology of
the sciatic nerve following stimulation. Bars indicate mean ± SEM. Values are the
means of 6–8 animals in each group. *P < 0.05 (ANOVA, Bonferroni post-test).ipsilateral dorsal horn of the C-ﬁbre stimulation group (data not
shown).
To further assess whether the C-ﬁbre stimulation protocol
caused direct damage to the sciatic nerve, microscopic examina-
tion of toluidine blue semi-thin sciatic nerve sections was per-
formed in C-ﬁbre and sham groups, 3 days after surgery (n = 3)
(Fig. 5B). This clearly demonstrated the lack of any signiﬁcant dif-
ferences between sham-operated and electrically stimulated sci-
atic nerves. Detailed examination failed to ﬁnd signiﬁcant
immune cell inﬁltration, axonal degeneration or abnormally swol-
len axons that are characteristic of nerve damaged tissue.
Together, these data clearly show that the behavioural changes
associated with C-ﬁbre strength sciatic nerve stimulation are not
associated with pathological changes in the nerve.
3.6. C-ﬁbre stimulation of neonatal sciatic nerve fails to induce
behavioural hypersensitivity or to alter Iba-1 expression pattern
Identical C-ﬁbre and sham stimulation protocols were em-
ployed as with adult rats except in 10-day old (P10) rats. Basal,
unstimulated, mechanical withdrawal thresholds were signiﬁ-
cantly lower than adult values, a phenomenon that has been
widely described elsewhere [13]. Both C-ﬁbre stimulated and sham
animals failed to develop any signiﬁcant mechanical hypersensitiv-
ity (Fig. 6A) following sciatic nerve stimulation. There were also no
signiﬁcant changes in the Iba-1 expression pattern in either of the
groups. Interestingly this also extended to the lateral dorsal horn
where the increase in Iba-1 immunoreactivity seen in the adult
that is associated with the surgical incision was also absent in both
the stimulated and sham groups (Fig. 6B). These results show that
considerable postnatal modiﬁcation of the immunological re-
sponse to high frequency nerve activity takes place and that the
lack of microglial activation may underpin the inability of neonatal
rats to exhibit behavioural sensitization following neuropathic
injury.4. Discussion
This study provides compelling in vivo evidence that the
microglial population of immunocompetent cells within the dorsal
horn of the spinal cord can be activated by a brief period of periph-
eral nerve C-ﬁbre stimulation, in the absence of pathology and this
can lead to signiﬁcant alterations in sensory processing within the
dorsal horn. The stimulus-evoked changes in microglial activation
were restricted to the somatotopic areas of the dorsal horn which
receive sciatic nerve input and were sufﬁcient to evoke signiﬁcant
and long-lasting changes in hindpaw mechanical sensitivity most
likely due to central sensitization of nearby dorsal horn neurons.
The hypersensitivity and alterations in Iba-1 expression pattern
are not seen in neonatal rats identifying a potentially important
maturational process that may underpin the inability of young ani-
mals to exhibit neuropathic pain behaviours following nerve
injury.
One of the central characteristics of networks within the spinal
dorsal horn is their ability to modify the efﬁcacy of synaptic con-
tact between the components of the network to either increase
or decrease the amount of sensory information relayed on to up-
stream sites. This central sensitization is triggered by intense noci-
ceptor stimulation, such as following tissue inﬂammation or nerve
damage [20,21] or repetitive electrical C-ﬁbre nociceptor stimula-
tion [8,54,65] and leads to enhanced excitatory synaptic transmis-
sion in the dorsal horn [8,12]. Various mechanisms have been
proposed to underlie central sensitization, including hetero- and
homosynaptic potentiation, transcription-dependent changes in
synaptic function and changes in the level of inhibition within
Fig. 6. (A) Electrically stimulating the sciatic nerve of P10 rat pups fails to induce any behavioural sensitization in either the ipsilateral or the contralateral paw. There were
also no changes in the expression pattern of Iba-1 immunoreactivity when compared to that in sham animals (B). Bars indicate mean ± SEM. Values are the means of 6–8
animals in each group.
116 G.J. Hathway et al. / PAIN 144 (2009) 110–118the dorsal horn [19,34,38,46,47,50,56,57]. The changes in dorsal
horn excitability which result from these processes can last from
minutes to days and are thought to underpin chronic pain states
[26,64].
Traditionally the interactions between the neuronal compo-
nents of the pain pathway have been the focus of research on cen-
tral sensitization, but more recently, interactions between neurons
and immune cells have been the focus of interest, particularly
microglia [22,36,52]. Microglia are derived from a hematopoietic
heritage and make up to 5–10% of the total glial population in
the CNS. Normally microglia are dormant, but once activated they
undergo a series of changes in morphology, gene expression, func-
tion and number [44]. A causal link has been shown to exist be-
tween the activation of microglia and the onset of chronic pain
following neuropathic lesions [23,58] and in vivo microinjection
of exogenously activated microglia leads to behavioural sensitivity
consistent with central sensitization [2,9,27,39].
To date the investigations into the involvement of endogenous
microglia in experimental models of pain have always assumed
that activation of these cells is dependent upon pathological mod-
iﬁcation of the tissue of interest. Microglia are analogous to macro-
phages and are known to play a role in the phagocytosis of cellular
debris [41,43] Nerve damage, which triggers intense microglial
activation, is accompanied by numerous injury-induced changes
in the nerve stump, cell bodies and central terminals, including
C-ﬁbre ectopic ﬁring and terminal atrophic changes [11,52] Here
we have shown that signiﬁcant changes in microglial distribution
in the dorsal horn that are associated with central sensitization
can occur without concomitant pathological modiﬁcation of the
peripheral innervation. The brief, low frequency C-ﬁbre stimula-
tion used here is a physiological rather than a pathological stimu-
lus and we observed no abnormal nerve ﬁbre proﬁles in ultra-thin
sciatic nerve sections, no decrease in IB4 or CGRP terminals in the
dorsal horn [17] and no increase in ATF-3, all sensitive markers of
neuronal damage in the DRG [59] following this protocol. Electricalstimulation can cause nerve damage [37] but the protocol used
here showed no evidence of this.
The behavioural sensitization we observed following electrical
stimulation of the sciatic nerve was more prolonged than that ob-
served with subcutaneous capsaicin, which selectively activates a
population of C-ﬁbres that express the TRPV1 receptor. This indi-
cates that brief localized activation of cutaneous C-ﬁbres alone is
not sufﬁcient to alter microglial markers in the dorsal horn, instead
a critical number of C-ﬁbres need to be stimulated or a critical
duration of stimulation is required to cause microglial activation.
The sciatic nerve is composed of a mixture of cutaneous and mus-
cle afferents. It may be that activating some subpopulations of C-ﬁ-
bres is particularly effective in inducing microglial activation [65].
C-ﬁbres are rapidly depolarised by topical application of capsaicin
but this is paralleled by conduction block within a few minutes
which will limit the C-ﬁbre activation [33].
Minocycline is a tetracycline antibiotic that has been found to
have numerous immunomodulatory activities. It inhibits the activ-
ity of matrix metalloproteinases, inducible nitric oxide synthase
(iNOS), and cyclooxygenase-2 (COX-2) and impairs the production
of cytokines such as Tumour necrosis factor-a (TNF-a) and inter-
leukin (IL)-1b. Another critical target of minocycline is the inhibi-
tion of the proliferation and activation of microglia and the
attenuation of T cell and microglial activation and microglial cyto-
kine production and the down regulation of microglial MHCIII
expression a [15,42]. Here we have concentrated on the effect of
minocycline upon microglia but we make no assumptions about
the mechanism by which this takes place. The ability of minocy-
cline to prevent both the behavioural sensitization and the upreg-
ulation of Iba-1 immunoreactivity simply illustrates the central
role that microglia play in the development of hyperalgesia. It
has previously been shown that minocycline is able to prevent
hyperalgesia when administered prior to either neuropathic or
inﬂammatory insult [3,45,66], here we show that it can prevent
C-ﬁbre stimulation-evoked hyperalgesia and microglial activation.
G.J. Hathway et al. / PAIN 144 (2009) 110–118 117Our data showing that neonatal rats do not become hyperalge-
sic and that the pattern of Iba-1 immunoreactivity does not change
following electrical stimulation of the sciatic nerve at C-ﬁbre inten-
sities are consistent with the previous studies, which show that
neonatal rats fail to express pain behaviours or activated microglia
in the dorsal horn following neuropathic injury [18,39]. Rats do not
express neuropathic pain until they are three weeks of age or older
at the time of injury. Consistent with human data [1] we have pre-
viously shown that intrathecal injection of activated adult microg-
lia to rats below P10 fails to cause behavioural hypersensitivity
whereas they cause signiﬁcant reductions in mechanical thresh-
olds from P14 and in adult rats [39]. This current study indicates
that P10 C-ﬁbre activation is not capable of activating microglia
or sensitizing behavioural responses.
Our results suggest that microglial activation and hyperalgesia
are directly triggered by release of a factor(s) either from C-ﬁbre
terminals or from C-ﬁbre activated postsynaptic cells in the dorsal
horn. The time period of our electrical stimulation makes transla-
tional or transcriptional changes within the DRG or dorsal horn
an unlikely contributor to this phenomenon. A plethora of
compounds are available for release from the central terminals of
C-ﬁbres; glutamate, ATP, substance P, somatostatin and BDNF
[6,29–31] as well as TNF-a and metalloproteinases [25] although
these are unlikely to be in high enough concentrations in undam-
aged DRG. Our quantitative analysis of mRNA of markers of
microglial activation in the dorsal horn following C-ﬁbre stimula-
tion suggests two phases of microglial activation. Compounds such
as IL-6 are upregulated immediately following stimulation, pro-
voking a microglial response. IL-6 has previously been shown to
play a role in neuropathic pain and is known to cause microglial
activation [67]. Mmp3 is a metallopeptidase that is known to cause
degradation of major components of the extracellular matrix [53]
and has recently been implicated inﬂammatory response [40].
The second phase corresponds to the migration of the activated
microglia to the portion of the dorsal horn which has received
the C-ﬁbre input. This was demonstrated by the increase in MCP-
1 (a chemokine involved in the recruitment of monocytes to sites
of injury) and moreover MCP-1 is readily released from neurons
[55] indicating a possible role in both the phases of the microglial
response. The upregulation we observed with CSF-1 is again indic-
ative of C-ﬁbre evoked microglial activation whilst the increases in
CD163 and absence of change in CD68 lead us to conclude that it is
resident microglia that are activated following our stimulation par-
adigm. Further studies are required to study these pathways in
more detail.
In conclusion we have shown that signiﬁcant changes in
sensory processing occur following the electrical activation of
C-ﬁbres in the sciatic nerve as a result of increased activation
and altered distribution of microglia in the dorsal horn of the
spinal cord. This is not the result of tissue damage but instead is
the result of the release of compound(s) from primary afferent
C-ﬁbres.
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